Drugs interactions for

0 Major drug interactions
15 Moderate drug interactions (including ingredients like Desogestrel, Dienogest, Drospirenone)
0 Minor drug interactions

15 interactions for

A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and .

Desogestrel

The risk or severity of thromboembolism can be increased when Desogestrel is combined with Human C1-esterase inhibitor.

Dienogest

The risk or severity of thromboembolism can be increased when Dienogest is combined with Human C1-esterase inhibitor.

Drospirenone

The risk or severity of thromboembolism can be increased when Drospirenone is combined with Human C1-esterase inhibitor.

Ethynodiol diacetate

The risk or severity of thromboembolism can be increased when Ethynodiol diacetate is combined with Human C1-esterase inhibitor.

Etonogestrel

The risk or severity of thromboembolism can be increased when Etonogestrel is combined with Human C1-esterase inhibitor.

Gestodene

The risk or severity of thromboembolism can be increased when Gestodene is combined with Human C1-esterase inhibitor.

Hydroxyprogesterone caproate

The risk or severity of thromboembolism can be increased when Hydroxyprogesterone caproate is combined with Human C1-esterase inhibitor.

Levonorgestrel

The risk or severity of thromboembolism can be increased when Levonorgestrel is combined with Human C1-esterase inhibitor.

Medroxyprogesterone acetate

The risk or severity of thromboembolism can be increased when Medroxyprogesterone acetate is combined with Human C1-esterase inhibitor.

Megestrol acetate

The risk or severity of thromboembolism can be increased when Megestrol acetate is combined with Human C1-esterase inhibitor.

Norelgestromin

The risk or severity of thromboembolism can be increased when Norelgestromin is combined with Human C1-esterase inhibitor.

Norethisterone

The risk or severity of thromboembolism can be increased when Norethisterone is combined with Human C1-esterase inhibitor.

Norgestimate

The risk or severity of thromboembolism can be increased when Norgestimate is combined with Human C1-esterase inhibitor.

Norgestrel

The risk or severity of thromboembolism can be increased when Norgestrel is combined with Human C1-esterase inhibitor.

Progesterone

The risk or severity of thromboembolism can be increased when Progesterone is combined with Human C1-esterase inhibitor.